Cargando…
Pathology assessment is necessary to validate translational endpoints in preclinical aging studies
The Geropathology Research Network has established a plan to identify and use pathology-based surrogate endpoints for aging intervention in preclinical drug studies to provide a predictable and short-term anti-aging drug response in line with clinical trials. The plan involves pathological assessmen...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Co-Action Publishing
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808080/ https://www.ncbi.nlm.nih.gov/pubmed/27015829 http://dx.doi.org/10.3402/pba.v6.31478 |